Private Market View

PepGen

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$112.5M
Last round
Later Stage VC (Series B)
Aug 2021
Valuation — not yet established

No valuation for PepGen is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($112.5M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·Watchlist + deal alerts for PepGen
Create free account
No card required

Funding history

2 rounds
DateRoundRaisedPost-money
Aug 2021Later Stage VC (Series B)$112.5M
Nov 2020Early Stage VC$14.4M

How PepGen's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For PepGen, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has PepGen raised?
PepGen has raised $112.5M in total funding across 2 recorded rounds.
When did PepGen last raise?
PepGen last raised in Aug 2021 (Later Stage VC (Series B)), raising $112.5M.